CNTC Stock Overview
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cannabotech LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪3.53 |
| 52 Week High | ₪15.88 |
| 52 Week Low | ₪2.60 |
| Beta | 0 |
| 1 Month Change | 0.31% |
| 3 Month Change | -26.37% |
| 1 Year Change | -77.56% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNTC | IL Personal Products | IL Market | |
|---|---|---|---|
| 7D | -13.1% | -0.06% | -0.7% |
| 1Y | -77.6% | -8.6% | 10.4% |
Return vs Industry: CNTC underperformed the IL Personal Products industry which returned -9.9% over the past year.
Return vs Market: CNTC underperformed the IL Market which returned 8.3% over the past year.
Price Volatility
| CNTC volatility | |
|---|---|
| CNTC Average Weekly Movement | 10.0% |
| Personal Products Industry Average Movement | 5.1% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.4% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: CNTC's share price has been volatile over the past 3 months.
Volatility Over Time: CNTC's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of IL stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | cannabotech.com |
CannaboTech Ltd engages in developing cannabinoid-based medication and healthcare products. It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products. The company is based in Rishon LeZion, Israel.
Cannabotech LTD Fundamentals Summary
| CNTC fundamental statistics | |
|---|---|
| Market cap | ₪6.41m |
| Earnings (TTM) | ₪0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs CNTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNTC income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪0 |
| Other Expenses | ₪0 |
| Earnings | ₪0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CNTC perform over the long term?
See historical performance and comparison